Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVEREXES: Everolimus + Exemestane in Advanced Breast Cancer
NCT03176238Phase 3Completed
- Sponsor
- Novartis
- Start
- Mar 2013
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 3 trial of everolimus in breast cancer, sponsored by Novartis. Started Mar 2013; status: completed.
02
Drugs
everolimus
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03176238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03176238.